Loading…
Based on limited metadata, GuruNanda LLC received an FDA Warning Letter on March 6, 2020, regarding drug products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning was issued within FDA's drug regulatory authority, but the specific issuing office and detailed violation count are not documented in this metadata summary. To understand the full scope and specific regulatory concerns, the complete warning letter text would be required.